"Cimetidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
Descriptor ID |
D002927
|
MeSH Number(s) |
D02.078.370.200 D03.383.129.308.130
|
Concept/Terms |
Cimetidine- Cimetidine
- N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine
SK&F-92334- SK&F-92334
- SK&F 92334
- SK&F92334
- SKF-92334
- SKF 92334
- SKF92334
|
Below are MeSH descriptors whose meaning is more general than "Cimetidine".
Below are MeSH descriptors whose meaning is more specific than "Cimetidine".
This graph shows the total number of publications written about "Cimetidine" by people in this website by year, and whether "Cimetidine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 1 | 3 | 4 |
1999 | 1 | 0 | 1 |
2000 | 0 | 2 | 2 |
2002 | 0 | 1 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cimetidine" by people in Profiles.
-
Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the childhood arthritis and rheumatology research alliance (CARRA) PFAPA work group. Pediatr Rheumatol Online J. 2020 Apr 15; 18(1):31.
-
Fever and sweats in the patient with advanced cancer. Hematol Oncol Clin North Am. 2002 Jun; 16(3):579-88, viii.
-
Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expression. Eur J Pharm Sci. 2000 Nov; 12(1):63-8.
-
Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity. Anticancer Drugs. 2000 Aug; 11(7):565-8.
-
Giant gastric ulcer: its natural history and outcome in the H2RA era. Am J Gastroenterol. 1999 Dec; 94(12):3478-86.
-
Report from the NASPGN Therapeutics Subcommittee. Cisapride and the attack of the P-450s. J Pediatr Gastroenterol Nutr. 1996 Nov; 23(4):395-7.
-
The management of refractory gastric ulcer using H2-receptor antagonists. Aliment Pharmacol Ther. 1996 Jun; 10(3):387-96.
-
Prophylaxis for stress-related gastrointestinal hemorrhage: a cost effectiveness analysis. Crit Care Med. 1996 Feb; 24(2):338-45.
-
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma. J Clin Oncol. 1996 Jan; 14(1):233-9.
-
Prophylaxis for stress-related gastric hemorrhage. Ann Intern Med. 1995 Apr 15; 122(8):632-3; author reply 633-4.